COgnitioN With VERiciGuat Evaluation in Heart Failure
Status:
RECRUITING
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
CONVERGE-HF is a 4-center pilot phase IIb randomized control trial in ambulatory patients with chronic heart failure (≥ 6 months) and mild-to-moderate cognitive impairment.
Phase:
PHASE2
Details
Lead Sponsor:
University of Alberta
Collaborators:
Heart and Stroke Foundation of Canada Ottawa Heart Institute Research Corporation